Abstract
Crizotinib is a tyrosine kinase inhibitor used to treat anaplastic lymphoma kinase-positive lung cancer. There is in vitro evidence that crizotinib ma......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
